Adient plc (FRA:18I)
Germany · Delayed Price · Currency is EUR | Market Cap | 1.53B +28.7% |
| Revenue (ttm) | 12.96B +3.9% |
| Net Income | 51.17M |
| EPS | 0.63 |
| Shares Out | n/a |
| PE Ratio | 29.99 |
| Forward PE | 8.86 |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | n/a |
| Open | 19.19 |
| Previous Close | 19.03 |
| Day's Range | 19.19 - 19.39 |
| 52-Week Range | 12.80 - 22.40 |
| Beta | n/a |
| Analysts | n/a |
| Price Target | n/a |
| Earnings Date | Aug 5, 2026 |
About Adient
Adient plc engages in the design, development, manufacture, and market of seating systems and components for passenger cars, commercial vehicles, and light trucks in United States. Its automotive seating solutions include complete seating systems, mechanisms, frames, foams, head restraints, armrests, and trim covers. The company serves automotive original equipment manufacturers in North America and South America; Europe, Middle East, and Africa; and Asia. Adient plc was incorporated in 2016 and is based in Dublin, Ireland. [Read more]
News
Adient price target raised to $29 from $26 at Barclays
Barclays raised the firm’s price target on Adient (ADNT) to $29 from $26 and keeps an Equal Weight rating on the shares.
Adient price target raised to $28 from $26 at Stifel
Stifel analyst Nathan Jones raised the firm’s price target on Adient (ADNT) to $28 from $26 and keeps a Buy rating on the shares.
Adient price target raised to $33 from $32 at UBS
UBS raised the firm’s price target on Adient (ADNT) to $33 from $32 and keeps a Buy rating on the shares.
Adient price target raised to $31 from $30 at Deutsche Bank
Deutsche Bank raised the firm’s price target on Adient (ADNT) to $31 from $30 and keeps a Buy rating on the shares.
Adient reports Q2 adjusted EPS 52c, consensus 44c
Reports Q2 revenue $3.87B, consensus $3.63B. The company said, “In Q2, we delivered solid results and continued to execute with discipline in a dynamic operating environment. Our teams remained focuse...
Adient raises FY26 revenue view to $14.8B from $14.6B, consensus $14.63B
Raises FY26 adjusted EBITDA view to $885M from $880M. Raises FY26 free cash flow view to $130M from $125M. Backs FY26 capital expenditures view $300M. The company said, “”Our strong…
Adient Earnings Call Transcript: Q2 2026
Q2 delivered 7% YoY revenue growth, with strong Americas and Asia performance offset by temporary inefficiencies and input cost headwinds. FY 2026 guidance was raised for revenue, adjusted EBITDA, and free cash flow, supported by new business wins, innovation, and a robust balance sheet.
Adient Slides: Q2 2026
Adient has posted slides in relation to its Q2 2026 quarterly earnings report, which was published on May 6, 2026.
Adient Earnings release: Q2 2026
Adient released its Q2 2026 earnings on May 6, 2026, summarizing the period's financial results.
Adient Quarterly report: Q2 2026
Adient has published its Q2 2026 quarterly earnings report on May 6, 2026.
Adient reports second quarter financial results
PLYMOUTH, Mich., May 6, 2026 /PRNewswire/ -- Adient (NYSE: ADNT), a global leader in automotive seating, today announced its second quarter 2026 financial results.
Adient acquires foam production plant in Romulus, MI from Woodbridge
Adient (ADNT) announced that it has expanded its operational footprint by acquiring a foam production plant in Romulus, MI. The plant, which produces foam for seats for multiple automaker customers,…
Adient acquires automotive seating foam plant in Romulus, MI
PLYMOUTH, Mich., April 27, 2026 /PRNewswire/ -- Adient (NYSE: ADNT), a global leader in automotive seating, today announced that it has expanded its operational footprint by acquiring a foam productio...
Adient Introduces ProForce Massage Flow Solution
PLYMOUTH, Mich., April 24, 2026 /PRNewswire/ -- Adient (NYSE: ADNT), a global leader in automotive seating, is advancing its mechanical massage portfolio with the commercialization of the ProForce Mas...
Adient price target lowered to $26 from $28 at JPMorgan
JPMorgan analyst Ryan Brinkman lowered the firm’s price target on Adient (ADNT) to $26 from $28 and keeps a Neutral rating on the shares. The firm adjusted targets in the…
Adient price target lowered to $30 from $33 at Deutsche Bank
Deutsche Bank analyst Edison Yu lowered the firm’s price target on Adient (ADNT) to $30 from $33 and keeps a Hold rating on the shares.
Citi upgrades Adient to Buy, opens ’90-day upside catalyst watch’
As previously reported, Citi analyst Michael Ward upgraded Adient (ADNT) to Buy from Neutral with a price target of $33, up from $30. Since the conflict started in the Middle…
Citi upgrades Adient to Buy, opens ’90-day upside catalyst watch’
As previously reported, Citi analyst Michael Ward upgraded Adient (ADNT) to Buy from Neutral with a price target of $33, up from $30. Since the conflict started in the Middle…
Adient upgraded to Buy from Neutral at Citi
Citi upgraded Adient (ADNT) to Buy from Neutral with a price target of $33, up from $30.
Adient price target lowered to $26 from $30 at Stifel
Stifel lowered the firm’s price target on Adient (ADNT) to $26 from $30 and keeps a Buy rating on the shares. The firm thinks Q1 earnings season is likely to…
Adient launches StepJoy foot massage innovation
PLYMOUTH, Mich., April 10, 2026 /PRNewswire/ -- As consumer expectations for in‑vehicle comfort continue to rise, Adient (NYSE: ADNT), a global leader in automotive seating, is expanding its massage o...
Adient to discuss Q2 fiscal 2026 financial results on May 6, 2026
PLYMOUTH, Mich., April 7, 2026 /PRNewswire/ -- Adient (NYSE: ADNT), a global leader in automotive seating, will host a conference call on May 6, 2026, at 8:30 a.m.
Adient price target lowered to $28 from $29 at Wells Fargo
Wells Fargo analyst Colin Langan lowered the firm’s price target on Adient (ADNT) to $28 from $29 and keeps an Overweight rating on the shares. The firm notes Q1 is…
Adient price target lowered to $26 from $27 at Barclays
Barclays lowered the firm’s price target on Adient (ADNT) to $26 from $27 and keeps an Equal Weight rating on the shares. The firm updated models in the autos and…
Adient reinstated with an Underperform at BofA
BofA reinstated coverage of Adient (ADNT) with an Underperform rating and $22 price target In the current environment where automakers are prioritizing cost reduction, the firm believes Adient’s expos...